Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
Appointed director
CC transcript
HI TECH PHARMACAL CO INC (HITK) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/21/2014 SC 13D/A GAMCO INVESTORS, INC. ET AL reports a 0% stake in Hi-Tech Pharmacal Co., Inc.
04/17/2014 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of Hi-Tech Pharmacal Co., Inc",
"Amended and Restated Bylaws of Hi-Tech Pharmacal Co., Inc",
"Akorn Completes Acquisition of Hi-Tech Pharmacal"
03/21/2014 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Separation Agreement and General Release"
03/20/2014 SC 13D/A GAMCO INVESTORS, INC. ET AL reports a 2.7% stake in Hi-Tech Pharmacal Co., Inc.
03/13/2014 SC 13D GAMCO INVESTORS, INC. ET AL reports a 2.7% stake in Hi-Tech Pharmacal Co., Inc.
03/12/2014 8-K Quarterly results
Docs: "Hi-Tech Pharmacal Reports Sales of $59.9 million for the Third Quarter Ended January 31, 2014 AMITYVILLE, N.Y"
03/11/2014 10-Q Quarterly Report for the period ended January 31, 2014
03/10/2014 SC 13G/A FMR LLC reports a 0.2% stake in HI-TECH PHARMACAL INC
02/11/2014 SC 13G AQR CAPITAL MANAGEMENT LLC reports a 9.2% stake in Hi-Tech Pharmacal Co., Inc.
02/10/2014 SC 13G/A AQR DELTA Master Acccount, L.P. reports a 5.4% stake in Hi-Tech Pharmacal Co., Inc.
02/07/2014 SC 13G/A BlackRock Inc. reports a 12.5% stake in HI-TECH PHARMACAL CO INC
01/31/2014 SC 13G/A BlackRock Inc. reports a 9.6% stake in HI-TECH PHARMACAL CO INC
01/10/2014 SC 13G/A FMR LLC reports a 9.8% stake in HI-TECH PHARMACAL INC
12/26/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Hi-Tech Pharmacal Announces Settlement Regarding Texas Pricing Investigation AMITYVILLE, N.Y"
12/19/2013 8-K Submission of Matters to a Vote of Security Holders
12/17/2013 4 April Gary M (President, HCP Division) has filed a Form 4 on HI TECH PHARMACAL CO INC
Txns: Sold 6,873 shares @ $43.06, valued at $296k
Exercised 1,875 options to buy @ $19.59, valued at $36.7k
Exercised 1,874 options to buy @ $22.25, valued at $41.7k
Exercised 3,124 options to buy @ $31.93, valued at $99.7k
12/10/2013 8-K Quarterly results
Docs: "Hi-Tech Pharmacal Reports Sales of $58.6 million for the Second Quarter Ended October 31, 2013 AMITYVILLE, N.Y"
12/10/2013 10-Q Quarterly Report for the period ended October 31, 2013
11/26/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/07/2013 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
10/11/2013 8-K Other Events
10/10/2013 4 SELTZER REUBEN (Vice Chairman, Business Dev't) has filed a Form 4 on HI TECH PHARMACAL CO INC
Txns: Sold 11,250 shares @ $43.13, valued at $485.2k
Exercised 11,250 options to buy @ $10.93, valued at $123k
10/10/2013 4 SELTZER DAVID S (CEO, President, Sec'y, Treas.) has filed a Form 4 on HI TECH PHARMACAL CO INC
10/08/2013 4 GOLDWYN MARTIN M (Director) has filed a Form 4 on HI TECH PHARMACAL CO INC
Txns: Sold 1,500 shares @ $43.1, valued at $64.7k
Exercised 1,500 options to buy @ $24.95, valued at $37.4k
10/08/2013 SC 13G AQR DELTA Master Acccount, L.P. reports a 5.3% stake in Hi-Tech Pharmacal Co., Inc.
10/04/2013 4 HIRSHAUT YASHAR (Director) has filed a Form 4 on HI TECH PHARMACAL CO INC
Txns: Exercised 11,250 options to buy @ $13.5, valued at $151.9k
10/04/2013 4 Simpson Bruce W (Director) has filed a Form 4 on HI TECH PHARMACAL CO INC
Txns: Sold 15,368 shares @ $43.15, valued at $663.1k
Sold 10,100 shares @ $43.14, valued at $435.7k
Exercised 12,375 options to buy @ $24.95, valued at $308.8k
Exercised 3,093 options to buy @ $5.83, valued at $18k
Exercised 2,500 options to buy @ $19.59, valued at $49k
Exercised 5,000 options to buy @ $22.25, valued at $111.3k
Exercised 2,500 options to buy @ $32.59, valued at $81.5k
10/04/2013 4 SELTZER REUBEN (Vice Chairman, Business Dev't) has filed a Form 4 on HI TECH PHARMACAL CO INC
Txns: Sold 11,250 shares @ $43.13, valued at $485.2k
Exercised 11,250 options to buy @ $13.5, valued at $151.9k
10/04/2013 4 PETERS WILLIAM J (EVP & CFO) has filed a Form 4 on HI TECH PHARMACAL CO INC
Txns: Sold 21,250 shares @ $43.11, valued at $916.1k
Exercised 15,000 options to buy @ $18.87, valued at $283.1k
Exercised 6,250 options to buy @ $5.83, valued at $36.4k
10/01/2013 4 GOLDWYN MARTIN M (Director) has filed a Form 4 on HI TECH PHARMACAL CO INC
Txns: Disposed of 4,308 shares @ $0
Sold 3,000 shares @ $43.1, valued at $129.3k
Disposed of 3,111 shares @ $0
Exercised 4,308 options to buy @ $13.5, valued at $58.2k
Exercised 3,000 options to buy @ $24.95, valued at $74.9k
Exercised 3,111 options to buy @ $13.5, valued at $42k
10/01/2013 4 April Gary M (President, HCP Division) has filed a Form 4 on HI TECH PHARMACAL CO INC
Txns: Sold 3,125 shares @ $43.08, valued at $134.6k
Exercised 3,125 options to buy @ $32.59, valued at $101.8k
09/16/2013 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment to the Letter Agreement of Gary M. April"
09/10/2013 8-K Quarterly results
09/09/2013 10-Q Quarterly Report for the period ended July 31, 2013
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy